000 01387 a2200409 4500
005 20250512013057.0
264 0 _c19891107
008 198911s 0 0 eng d
022 _a0732-8893
024 7 _a10.1016/0732-8893(89)90065-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBianchini, H N
245 0 0 _aA ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
_h[electronic resource]
260 _bDiagnostic microbiology and infectious disease
_c
300 _a45S-50S p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _a4-Quinolones
650 0 4 _aAnti-Infective Agents
_xpharmacology
650 0 4 _aArgentina
650 0 4 _aBacteria
_xdrug effects
650 0 4 _aFluoroquinolones
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aQuinolones
700 1 _aSarachian, B
700 1 _aFernandez, A
700 1 _aPaolasso, R
700 1 _aKaufman, C
700 1 _aNotario, R
700 1 _aPorven, G
700 1 _aIngaramo, R A
700 1 _aPerez, S
700 1 _aFerrero, S M
773 0 _tDiagnostic microbiology and infectious disease
_gvol. 12
_gno. 3 Suppl
_gp. 45S-50S
856 4 0 _uhttps://doi.org/10.1016/0732-8893(89)90065-5
_zAvailable from publisher's website
999 _c2682216
_d2682216